Skip to main content
Clinical Trials/IRCT20160305026917N2
IRCT20160305026917N2Not yet recruitingPhase 3

Investigating the effect of oral supplementation containing jujube and saffron on recovery and controlling the symptoms of patients with covid-19

Birjand University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to 70 years (—)
Sex
All

Inclusion Criteria

  • Clinical or paraclinical confirmation of disease
  • Absence of underlying disease including diabetes, thyroid disorders, cardiovascular, autoimmune, and hemorrhagic and other lung diseases
  • No pregnancy and breastfeeding.

Exclusion Criteria

  • Patients with severe forms of the disease (patients under ventilator, patients with oxygen saturation below 88 mm Hg, and patients admitted to the ICU
  • The patient's unwillingness to continue participating in the project
  • Sensitivity to the components of the supplement.

Investigators

Similar Trials

The effect of jujube and saffron... | Clinical Trial